FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Anhui Welcome Foreign Trade Pi yen chin Ophthalmic Redness Reliever Recall

Pi yen chin Ophthalmic Redness Reliever Drops Made in China

ANHUI WELCOME FOREIGN TRADE CO.,LTD. · Hefei, N/A

Risk level
Class II
Reported by FDA
Sep 1, 2021
Recall ID
D-0755-2021
Check your lot numberHow we source this data

Summary

Anhui Welcome Foreign Trade recalled Pi yen chin Ophthalmic Redness Reliever starting Aug 12, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0755-2021 on Sep 1, 2021. Reason: Labeling: Not Elsewhere Classified; The packaging states these are ophthalmic drops. However, they are manufactured as nasal drops and sterility cannot be assured. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified; The packaging states these are ophthalmic drops. However, they are manufactured as nasal drops and sterility cannot be assured.

Product description

Pi yen chin Ophthalmic Redness Reliever Drops Made in China, Net Wt.: 10 ml (0.34 fl/oz) Exclusive U.S. Distributor: (Chinese writing)International Nature Nutraceuticals, Inc. New York, NY 10002 www.INNHERB.com. Konzon NDC 51367-008-10

Lot numbers, UPCs & expiration codes

Lot 180901 Exp: 8/2021 Lot 190601 Exp: 5/2022 Lot 191201 Exp: 11/2022 Lot 200701 Exp:6/2023 Lot 201101 Exp: 10/2023 Lot 210501 Exp: 4/2024

Where it was sold

Distributed to: INTERNATIONAL NATURE NUTRACEUTICALS.INC. 39 BOWERY PMB 193,NEW YORK,NY 10002,U.S.A.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0755-2021
Classification
Class II
Status
Terminated
Recall initiated
Aug 12, 2021
FDA report date
Sep 1, 2021
Quantity
63,750
Recall type
Voluntary: Firm initiated
Recalling firm
ANHUI WELCOME FOREIGN TRADE CO.,LTD.

Original FDA data

Every field from FDA enforcement report D-0755-2021, exactly as published.

Show all FDA fields
City
Hefei
Status
Terminated
Country
China
Event ID
88371
Address
Changhe Kechuang Mansion Room 1602
Address (line 2)
No. 677 Changjiang West Rd
Code information
Lot 180901 Exp: 8/2021 Lot 190601 Exp: 5/2022 Lot 191201 Exp: 11/2022 Lot 200701 Exp:6/2023 Lot 201101 Exp: 10/2023 Lot 210501 Exp: 4/2024
Report date
Sep 1, 2021
Product type
Drugs
Recall number
D-0755-2021
Classification
Class II
Recalling firm
ANHUI WELCOME FOREIGN TRADE CO.,LTD.
Product quantity
63,750
Termination date
Dec 23, 2021
Reason for recall
Labeling: Not Elsewhere Classified; The packaging states these are ophthalmic drops. However, they are manufactured as nasal drops and sterility cannot be assured.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pi yen chin Ophthalmic Redness Reliever Drops Made in China, Net Wt.: 10 ml (0.34 fl/oz) Exclusive U.S. Distributor: (Chinese writing)International Nature Nutraceuticals, Inc. New York, NY 10002 www.INNHERB.com. Konzon NDC 51367-008-10
Distribution pattern
Distributed to: INTERNATIONAL NATURE NUTRACEUTICALS.INC. 39 BOWERY PMB 193,NEW YORK,NY 10002,U.S.A.
Recall initiation date
Aug 12, 2021
Initial firm notification
Letter
Center classification date
Aug 20, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0755-2021, published Sep 1, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls